VIR · Vir Biotechnology, Inc.
$8.65
-0.20 (-2.26%)
At close · Jul 29
Market Cap
$1.49B
Shares
168.65M
Positioning
Aug 21, 2026 · 23 days to expiry · 34 contractsPut / call OI
7.19
Put-heavy positioning
Open interest
1,311
contracts outstanding
Volume
74
traded today
Max pain
$10.00
$1.35 above spot
ATM implied vol
114.3%
market's expected move
Open interest by strike
Calls
Puts
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | 785.3% | 0.981 | — | — | — | — | — | 0 | |
| 0 | — | 473.3% | 0.966 | — | — | — | — | — | 0 | |
| 0 | — | 347.3% | 0.949 | — | — | — | — | — | 0 | |
| 5 | 5 | 281% | 0.925 | $6.50 | — | — | — | — | 0 | |
| 0 | — | 283.7% | 0.867 | — | — | — | — | — | 0 | |
| 0 | — | 221.1% | 0.82 | — | $0.05 | — | — | 10 | 26 | |
| 0 | — | 175.7% | 0.748 | — | — | -0.197 | 111.1% | — | 0 | |
| 0 | — | 106.7% | 0.646 | — | $0.30 | -0.315 | 63.5% | 3 | 817 | |
| 6 | 5 | 130% | 0.5 | $0.55 | $0.82 | -0.538 | 98.6% | 1 | 291 | |
| 50 | 28 | 97.3% | 0.298 | $0.61 | $0.90 | -0.903 | 48.2% | 15 | 17 | |
| 80 | 1 | 112.1% | 0.224 | $0.27 | — | -0.964 | 58% | — | 0 | |
| 5 | 1 | 156.7% | 0.252 | $0.25 | — | — | — | — | 0 | |
| 0 | — | 176.3% | 0.233 | — | — | -0.863 | 134.4% | — | 0 | |
| 0 | — | 201.5% | 0.234 | — | — | — | — | — | 0 | |
| 7 | 3 | 211.4% | 0.209 | $0.06 | — | — | — | — | 0 | |
| 3 | 1 | 226.4% | 0.2 | $0.10 | — | — | — | — | 0 | |
| 4 | 1 | 237.9% | 0.193 | $0.05 | — | — | — | — | 0 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.
Key facts
CIK
1706431
CUSIP
92764N102
13F (30d)
38 filings
38 filers
Visit website
Investor relations